Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 5 |
NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: A4IDM0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 181 | 185 | PF00656 | 0.698 |
CLV_NRD_NRD_1 | 109 | 111 | PF00675 | 0.583 |
CLV_NRD_NRD_1 | 148 | 150 | PF00675 | 0.682 |
CLV_NRD_NRD_1 | 2 | 4 | PF00675 | 0.752 |
CLV_NRD_NRD_1 | 65 | 67 | PF00675 | 0.599 |
CLV_NRD_NRD_1 | 73 | 75 | PF00675 | 0.524 |
CLV_PCSK_KEX2_1 | 108 | 110 | PF00082 | 0.564 |
CLV_PCSK_KEX2_1 | 123 | 125 | PF00082 | 0.439 |
CLV_PCSK_KEX2_1 | 131 | 133 | PF00082 | 0.526 |
CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.752 |
CLV_PCSK_KEX2_1 | 72 | 74 | PF00082 | 0.553 |
CLV_PCSK_PC1ET2_1 | 123 | 125 | PF00082 | 0.569 |
CLV_PCSK_PC1ET2_1 | 131 | 133 | PF00082 | 0.526 |
CLV_PCSK_PC1ET2_1 | 72 | 74 | PF00082 | 0.553 |
CLV_PCSK_SKI1_1 | 117 | 121 | PF00082 | 0.654 |
CLV_PCSK_SKI1_1 | 7 | 11 | PF00082 | 0.675 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.760 |
DOC_PP2B_LxvP_1 | 25 | 28 | PF13499 | 0.543 |
DOC_USP7_MATH_1 | 26 | 30 | PF00917 | 0.690 |
DOC_WW_Pin1_4 | 7 | 12 | PF00397 | 0.557 |
LIG_14-3-3_CanoR_1 | 164 | 172 | PF00244 | 0.606 |
LIG_14-3-3_CanoR_1 | 20 | 28 | PF00244 | 0.671 |
LIG_FHA_1 | 10 | 16 | PF00498 | 0.700 |
LIG_FHA_1 | 165 | 171 | PF00498 | 0.675 |
LIG_FHA_2 | 59 | 65 | PF00498 | 0.616 |
LIG_FHA_2 | 84 | 90 | PF00498 | 0.629 |
LIG_LIR_Apic_2 | 90 | 96 | PF02991 | 0.625 |
LIG_SH2_STAT5 | 41 | 44 | PF00017 | 0.515 |
LIG_TRAF2_1 | 152 | 155 | PF00917 | 0.404 |
LIG_TRAF2_1 | 95 | 98 | PF00917 | 0.600 |
MOD_CK1_1 | 29 | 35 | PF00069 | 0.633 |
MOD_CK1_1 | 40 | 46 | PF00069 | 0.672 |
MOD_CK2_1 | 165 | 171 | PF00069 | 0.647 |
MOD_DYRK1A_RPxSP_1 | 7 | 11 | PF00069 | 0.523 |
MOD_GlcNHglycan | 29 | 32 | PF01048 | 0.639 |
MOD_GlcNHglycan | 42 | 45 | PF01048 | 0.664 |
MOD_GSK3_1 | 15 | 22 | PF00069 | 0.673 |
MOD_GSK3_1 | 186 | 193 | PF00069 | 0.737 |
MOD_GSK3_1 | 26 | 33 | PF00069 | 0.574 |
MOD_NEK2_1 | 55 | 60 | PF00069 | 0.691 |
MOD_PIKK_1 | 19 | 25 | PF00454 | 0.645 |
MOD_PKA_2 | 19 | 25 | PF00069 | 0.688 |
MOD_PKA_2 | 58 | 64 | PF00069 | 0.662 |
MOD_Plk_1 | 37 | 43 | PF00069 | 0.625 |
MOD_Plk_4 | 37 | 43 | PF00069 | 0.555 |
MOD_ProDKin_1 | 7 | 13 | PF00069 | 0.557 |
MOD_SUMO_rev_2 | 180 | 188 | PF00179 | 0.660 |
TRG_DiLeu_BaEn_4 | 97 | 103 | PF01217 | 0.590 |
TRG_ER_diArg_1 | 1 | 3 | PF00400 | 0.770 |
TRG_ER_diArg_1 | 108 | 110 | PF00400 | 0.623 |
TRG_ER_diArg_1 | 57 | 60 | PF00400 | 0.710 |
TRG_ER_diArg_1 | 73 | 76 | PF00400 | 0.482 |
TRG_Pf-PMV_PEXEL_1 | 73 | 77 | PF00026 | 0.669 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0P0M8 | Trypanosomatidae | 53% | 100% |
A0A3Q8IGG6 | Leishmania donovani | 98% | 100% |
A4HPV8 | Leishmania braziliensis | 68% | 100% |
E9ATM5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 99% |
Q4Q0X3 | Leishmania major | 91% | 100% |